维普期刊资源整合服务平台（V6.5）

41篇 您的检索式：作者名="Tavridou"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Need for reassessment of reported CYP2C19 allele frequencies in various populations in view of CYP2C19 * 17 discovery: the case of Greece显示文摘	Ragia G Arvanitidis KI Tavridou A	2009	Pharmacogenomics2009，10，1：	1
2	Association of hy- perandrogenemic and metabolic phenotype with carotid intima - media thickness in young women with polycystic ovary syndrome显示文摘	Vryonidou A Papatheodorou A Tavridou	2005	J Clin Endocrinol Metab2005，90，5：	1
3	Atorvastatin and simvastatin decrease the uptake of acetylated low-density lipoprotein by human monocytes显示文摘	Tavridou A Manolopoulos VG	2005	Pharmacology2005，73，：	1
4	Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas显示文摘	Ragia G Petridis I Tavridou A		0，，11：	1
5	Association of KCNJ11 E23K gene polymorphism with hypoglycemia in sulfonylurea-treated Type 2 diabetic patients显示文摘	Ragia G Tavridou A Petridis I		0，，01：	1
6	Antioxidant effects of simvastatin in primary and secondary prevention of coronary heart disease 显示文摘	TAVRIDOU A EFTHIMIADIS A EFTHIMIADIS I	2006	Eur J Clin Phaln2006，62，6：	1
7	Antioxidant effect- sand the therapeutic mode of action of calcium channel blocker sin hypertension and atherosclerosis 显示文摘	Tavridou A Kaklamanis L Papalois A	2007	J Pharmacol Exp Ther2007，323，3：	1
8	Antioxidant effects of simvastatin in primary and secondary prevention of coronary heart disease显示文摘	Tavridou A Efthimiadis A Efthimiadis I	2006	Eur J Clin Pharmacol2006，62，6：	1
9	EP2306 , A Novel Squalene Synthase Inhibitor, Reduces Atherosclemsis in the Cholesterol-Fed Rabbit显示文摘	Tavridou A Kaklamanis L Papalois A	2008	The Journal of Pharmacology and Experimantal Therapeutics2008，323，3：	1
10	New aspects on the metabolic role of intestinal microbiota in the development of athcrosclerosis显示文摘	Drosos I Tavridou A Kolios G	2015	Metabolism2015，64，47：	1
11	Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective 显示文摘	Manolopoulos VG Ragia G Tavridou A	2011	Pharmacogenomics2011，12，8：	1
12	Lack of association of the p450 oxidoreductase * 28 single nucleotide polymorphism with the lipid -lowering effect of statins in hypercholesterolemic patients 显示文摘	RAGIA G KOLOVOU V TAVRIDOU A	2014	Mol Diagn Ther2014，18，3：	1
13	G894T polymorphism of eNOS gene is a predictor of response to combination of inhaled corticosteroids with long-lasting beta2-agonists in asthmatic children显示文摘	Iordanidou M Paraskakis E Tavridou A	2012	Pharmacogenomics2012，13，12：	1
14	Antioxidant effects of simvastatin in primary and secondary prevention of coronary heart disease 显示文摘	Tavridou A Efthimiadis A Efihimiadis I	2006	Eur J Clin Pharmacol2006，62，6：	1
15	Need for reassess ment of reported CYP2C19 allele frequencies in various populations in view of CYP2C19 * 17 discovery: the case of Greece 显示文摘	Ragia G Arvanitidis K I Tavridou A	2009	Pharmacogenomics2009，10，1：	1
16	Presence of CYP2C9 * 3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas 显示文摘	Ragia G Petridis I Tavridou A	2009	Pharmacogenomics2009，10，11：	1
17	EP2306 , a novel squalene synthase inhibitor, reduces atheroselerosis in the cholesterol-fed rabbit 显示文摘	Tavridou A Kaklamanis L Papalois A	2008	J Pharmacol Exper Therapeu2008，，：	1
18	The seroto- nin transporter promoter polymorphism (5-HTTLPR) is associated with type 2 diabetes显示文摘	Iordanidou M Tavridou A Petridis I	2010	Clin Chim Acta2010，411，34：	1
19	Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis显示文摘	Tavridou A Kaklamanis L Papalois A		0，，03：	1
20	Antioxidant properties of two novel 2-biphenylmorpholine compounds (EP2306 and EP2302) in vitro and in vivo显示文摘	TAVRIDOU A MANOLOPOULOS VG	2004	Eur J Pharmacol2004，505，13：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示